Manmeet Singh Ahluwalia

Professor of Translational Medicine

Florida International University Herbert Wertheim College of Medicine

United States

Research Interests

Explore related searches

Professors in United States

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Manmeet Singh Ahluwalia is a Professor of Translational Medicine at Florida International University Herbert Wertheim College of Medicine, USA. His research focuses on brain tumors, health disparities in cancer treatment, and innovative therapeutic approaches, as evidenced by his recent studies on liquid biopsy techniques and treatment outcomes in glioblastoma patients. He is dedicated to advancing medical education and addressing inequities within the healthcare workforce.

Articles (20)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

Year:

2023

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Manmeet Singh Ahluwalia

Research Interests

Explore related searches

Contact this professor

About

Articles (20)

Phase I Study of Adavosertib with Radiotherapy and Temozolomide in Newly Diagnosed Glioblastoma and Intratumoral Drug Levels in Recurrent Glioblastoma

Preanalytical variables and analytes in liquid biopsy approach for brain tumors: A comprehensive review and recommendations from the RANO Group and the Brain Liquid Biopsy Consortium

Survival in Patients with Colorectal Cancer and Isolated Brain Metastases: Temporal Trends and Prognostic Factors from the National Cancer Database (2010–2020)

Association of Health Disparities with Glioblastoma Treatment and Outcomes: Insights from a 15-Year National Cohort (2005–2020)

Guiding principles for adult CNS tumor treatment programs

Stratification algorithm for repetitive TMS in stroke (START): Results from an exploratory crossover study

Financial barriers and inequity in medical education in India: challenges to training a diverse and representative healthcare workforce

Evaluating the Safety of Immune Checkpoint Inhibitors and Combination Therapies in the Management of Brain Metastases: A Comprehensive Review

Clinical Validation of a Cell-Free DNA Fragmentome Assay for Augmentation of Lung Cancer Early Detection

Immune Checkpoint Inhibitors in the Management of Brain Metastases from Non-Small Cell Lung Cancer: A Comprehensive Review of Current Trials, Guidelines and Future Directions

Endoglin inhibitor TRC105 with or without bevacizumab for bevacizumab-refractory glioblastoma (ENDOT): a multicenter phase II trial

Combination of EGFR-Directed Tyrosine Kinase Inhibitors (EGFR-TKI) with Radiotherapy in Brain Metastases from Non-Small Cell Lung Cancer: A 2010–2019 Retrospective Cohort Study

First- versus Third-Generation EGFR Tyrosine Kinase Inhibitors in EGFR-Mutated Non-Small Cell Lung Cancer Patients with Brain Metastases

Authorship Diversity in Global Evidence Synthesis in Urology: 1998-2022 Analysis of Cochrane Reviews.

Impact of COVID-19 in patients on active melanoma therapy and with history of melanoma.

DNA Methylation and Histone Modification in Low-Grade Gliomas: Current Understanding and Potential Clinical Targets.

EGFR Pathway Expression Persists in Recurrent Glioblastoma Independent of Amplification Status.

Key Clinical Principles in the Management of Glioblastoma.

Key Clinical Principles in the Management of Glioblastoma

Collaborators (7)

Carlos G Romo

Ahmad Ozair

Andrew Dhawan

Vivek Bhat

Heather Nelson

Tahir Latif

Philipp Dahm

Make your next move.